Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
data integrity
CRO
FDA asks for study do-overs at 2 CROs due to data concerns
The FDA has asked biopharmas to repeat studies they had already conducted at two CROs in India.
Kyle LaHucik
Sep 28, 2021 1:04pm
Troubled Immunomedics tries again at FDA after rejection
Dec 5, 2019 7:20am
AstraZeneca buy Acerta faked cancer drug data, company admits
Oct 16, 2017 9:57am
Chutes & Ladders—Eli Lilly vet Derica Rice to retire as CFO
Jun 1, 2017 10:38pm
Faking clinical trial data could face criminal charges in China
Apr 13, 2017 8:20am
Dishonest participants, another chapter of China’s fake data story
Jan 18, 2017 7:00am
